Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00786903|
Recruitment Status : Completed
First Posted : November 6, 2008
Last Update Posted : April 3, 2015
Robert Krause, MD
Information provided by (Responsible Party):
Robert Krause, MD, Medical University of Graz
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||April 2015|
|Actual Study Completion Date :||April 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Krause R, Zollner-Schwetz I, Salzer HJ, Valentin T, Rabensteiner J, Prüller F, Raggam R, Meinitzer A, Prattes J, Rinner B, Strohmaier H, Quehenberger F, Strunk D, Heidrich K, Buzina W, Hoenigl M. Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls. J Infect Dis. 2015 Feb 1;211(3):445-51. doi: 10.1093/infdis/jiu468. Epub 2014 Aug 22.